Impaired innate COPD alveolar macrophage responses and toll-like receptor-9 polymorphisms

PLoS ONE

Volumn 10, Issue 9, 2015, Pages

  Berenson, Charles S ^a   Kruzel, Ragina L ^a   Wrona, Catherine T ^a   Mammen, Manoj J ^a   Sethi, Sanjay ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; ASPARTIC ACID; CYTOSINE; DNA; GLUTAMINE; GLYCINE; INTERLEUKIN 8; ISOLEUCINE; THREONINE; THYMINE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CYTOKINE RESPONSE; DISEASE SEVERITY; DNA PURIFICATION; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GENE AMPLIFICATION; HAEMOPHILUS INFLUENZAE; HUMAN; HUMAN CELL; INNATE IMMUNITY; LUNG ALVEOLUS MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MORAXELLA CATARRHALIS; PROTEIN EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; STREPTOCOCCUS PNEUMONIAE; ALLELE; AMINO ACID SUBSTITUTION; BIOSYNTHESIS; CASE CONTROL STUDY; GENE FREQUENCY; GENETICS; IMMUNOLOGY; LUNG FUNCTION TEST; METABOLISM; PATHOPHYSIOLOGY;

ALLELES; AMINO ACID SUBSTITUTION; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; HUMANS; IMMUNITY, INNATE; INTERLEUKIN-8; MACROPHAGES, ALVEOLAR; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; TOLL-LIKE RECEPTOR 9;

EID: 84959220654     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0134209     Document Type: Article

References (40)

1. Wilkinson TM, Patel IS, Wilks M, Donaldson GC, Wedzicha JA. Airway bacterial load and FEV1 decline in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2003; 167: 1090-1095.
2. Hill AT, Campbell EJ, Hill SL, Bayley DL, Stockley RA. Association between airway bacterial load and markers of airway inflammation in patients with stable chronic bronchitis. Am J Med. 2000; 109: 288-295.
3. Sethi S, Murphy TF. Bacterial infection in chronic obstructive pulmonary disease in 2000: A state-ofthe-Art review. Clin Microbiol Rev. 2001; 14: 336-363.
4. Murphy TF. The role of bacteria in airway inflammation in exacerbations of chronic obstructive pulmonary disease. Curr Opin Infect Dis. 2006; 19: 225-230.
5. Berenson CS, Wrona CT, Grove LJ, Maloney J, Garlipp MA, Wallace PK, et al. Impaired alveolar macrophage response to Haemophilus antigens in chronic obstructive lung disease. Am J Resp Crit Care Med. 2006; 174: 31-40.
6. Berenson CS, Garlipp MA, Grove LJ, Maloney J, Sethi S. Impaired phagocytosis of nontypeable Haemophilus influenzae by human alveolar macrophages in chronic obstructive pulmonary disease. J Infect Dis. 2006; 194: 1375-1384.
7. Berenson CS, Kruzel RL, Eberhardt E, Sethi S. Phagocytic dysfunction of human alveolar macrophages and severity of chronic obstructive pulmonary disease. J Infect Dis. 2013; 208: 2036-2045. doi: 10.1093/infdis/jit400
8. Berenson CS, Kruzel RL, Eberhardt E, Dolnick R, Minderman H, Wallace PK, et al. Impaired innate immune alveolar macrophage response and the predilection for COPD exacerbations. Thorax 2014; 69: 811-818. doi: 10.1136/thoraxjnl-2013-203669
9. Shuto T, Xu H, Wang B, Han J, Kai H, Gu XX, et al. Activation of NF-kappa B by nontypeable Hemophilus influenzae is mediated by toll-like receptor 2-TAK1-dependent NIK-IKK alpha/beta-I kappa B alpha and MKK2/6-p38 MAP kinase signaling pathways in epithelial cells. Proc Natl Acad Sci. 2001; 98: 8774-8779.
10. Berenson CS, Murphy TF, Wrona CT, Sethi S. Outer membrane protein P6 of nontypeable Haemophilus influenzae is a potent and selective inducer of human macrophage proinflammatory cytokines. Infect Immun. 2005; 73: 2728-2735.
11. Schroeder NW, Schumann RR. Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious disease. Lancet Infect Dis. 2005; 5: 156-164.
12. Arbour NC, Lorenz E, Schutte BC, Zabner J, Kline JN, Jones M, et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nature Genetics 2000; 25: 187-191.
13. Michel O, LeVan TD, Stern D, Dentener M, Thorn J, Gnat D, et al. Systemic responsiveness to lipopolysaccharide and polymorphisms in the toll-like receptor 4 gene in human beings. J Allergy Clin Immunol. 2003; 112: 923-929.
14. Schwartz DA, Cook DN. Polymorphisms of the Toll-like receptors and human disease. Clin Infect Dis. 2005; 41(Suppl 7): S403-407.
15. Sabroe I, Whyte MK, Wilson AG, Dower SK, Hubbard R, Hall I. Toll-like receptor (TLR) 4 polymorphisms and COPD. Thorax 2004; 59: 81.
16. Speletas M, Merentiti V, Kostikas K, Liadaki K, Minas M, Gourgoulianis K, et al. Association of TLR4-T399I polymorphism with chronic obstructive pulmonary disease in smokers. Clin Dev Immunol. 2014; doi: 10.1155/2009/260286
17. Rohde G, Klein W, Arinir U, Hagedorn M, Duerig NT Bauer T, et al. Association of the Asp299Gly TLR4 polymorphism with COPD. Respir Med. 2006; 100: 892-896.
18. Pabst S, Bradler O, Gillissen A, Nickenig G, Skowasch D, Grohe C. Toll-like receptor polymorphisms in sarcoidosis and chronic obstructive pulmonary disease. Adv Exp Med Biol. 2013; 756: 239-245. doi: 10.1007/978-94-007-4549-0-30
19. Carvalho A, Pasqualotto AC, Pitzurra L, Romani L, Denning DW, Rodrigues F. Polymorphisms in tolllike receptor genes and susceptibility to pulmonary aspergillosis. J Infect Dis. 2008; 197: 618-621. doi: 10.1086/526500
20. Mailaparambil B, Krueger M, Heinze J, Forster J, Heinzmann A. Polymorphisms of toll like receptors in the genetics of severe RSV associated diseases. Dis Markers 2008; 25: 59-65.
21. Schroder NW, Hermann C, Hamann L, Gobel UB, Schumann RR. High frequency of polymorphism Arg753Gln of the Toll-like receptor-2 gene detected by a novel allele-specific PCR. J Mol Med. 2003; 81: 368-372.
22. Folwaczny M, Gals J, Torok HP, Limbersky O, Folwaczny C. Toll-like receptor (TLR) 2 and 4 mutations in periodontal disease. Clin Exp Immunol. 2004; 135: 330-335.
23. Hamann L, Hamprecht A, Gomma A, Schumann RR. Rapid and inexpensive real-Time PCR for genotyping functional polymorphisms with the Toll-like receptor-2,-4, and-9 genes. J Immunol Methods 2004; 285: 281-291.
24. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2007; 176: 532-555.
25. Texereau J, Chiche J-D, Taylor W, Choukroun G, Comba B, Mira J-P. The importance of Toll-like receptor 2 polymorphisms in severe infections. Clin Infect Dis. 2005; 41(Suppl 7): S408-415.
26. Ferwerda B, McCall MB, Verheijen K, Kullberg B-J, van der Ven AJ, van der Meer JW, Netea MG. Functional consequences of toll-like receptor 4 polymorphisms. Mol Med. 2008; 14: 346-352. doi: 10.2119/2007-00135.Ferwerda
27. Graffelman J. Exploring Diallelic Genetic Markers: The Hardy Weinberg Package. J Statistical Software 2015; 64: 1-22
28. Abreu MT, Fukata M, Arditi M. TLR signaling in the gut in health and disease. J Immunol. 2005; 174: 4453-4460.
29. Franchimont D, Vermeire S, El Housni H, Pierik M, Van Steen K, Gustot T, et al. Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitis. Gut 2004; 53: 987-992.
30. Török HP, Glas J, Endres I, Tonenchi L, Teshome MY, Wetzke M, et al. Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease. Am J Gastroenterol. 2009; 104: 1723-1736. doi: 10.1038/ajg.2009.184
31. Ito M, Hanaoka M, Droma Y, Kobayashi N, Yasuo M, Kitaguchi Y, et al. The association of Toll-like receptor 4 gene polymorphisms with the development of emphysema in Japanese subjects: A case control study. BMC Res Notes 2012; 18;5:36. doi: 10.1186/1756-0500-5-36
32. Pabst S, Yenice V, Lennarz M, Tuleta I, Nickenig G, Gillissen A, et al. Toll-like receptor 2 gene polymorphisms Arg677Trp and Arg753Gln in chronic obstructive pulmonary disease. Lung 2009; 187: 173-178.
33. Vollmer J. TLR9 in health and disease. Int Rev Immunol. 2006; 25: 155-181.
34. Ng MT, van't Hof R, Crockett JC, Hope ME, Berry S, Thomson J, et al. Increase in NF-kB binding affinity of the variant C allele of the toll-like receptor 9-1237T/C polymorphism is associated with Helicobacter pylori-induced gastric disease. Infect Immun. 2010; 78: 1345-1352. doi: 10.1128/IAI.01226-09
35. Lazarus R, Klimecki WT, Raby BA, Vercelli D, Palmer LJ, Kwiatkowski DJ, et al. Single-nucleotide polymorphisms in the Toll-like receptor 9 gene (TLR9): frequencies, pairwise linkage disequilibrium, and haplotypes in three U.S. ethnic groups and exploratory case-control disease association studies. Genomics 2003; 81: 85-91.
36. Noguchi E, Nishimura F, Fukai H, Kim J, Ichikawa K, Shibasaki M, et al. An association study of asthma and total serum immunoglobin E levels for Toll-like receptor polymorphisms in a Japanese population. Clin Exp Allergy 2004; 34: 177-183.
37. Berghofer B, Frommer T, Konig IR, Ziegler A, Chakraborty T, Bein G, et al. Common human Toll-like receptor 9 polymorphisms and haplotypes: Association with atopy and functional relevance. Clin Exp Allergy 2005; 35: 1147-1154.
38. Yang HY, Lu KC, Lee HS, Huang SM, Lin YF, Wu CC, et al. Role of the functional Toll-like receptor-9 promoter polymorphism (-T1237T/C) in increased risk of end-stage renal disease: A case control study. PLoS One 2013; 8: e58444. doi: 10.1371/journal.pone.0058444
39. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004; 118: 229-241.
40. Budulac SE, Boezen HM, Hiemstra PS, Lapperre TS, Vonk JM, Timens W, et al. Toll-like receptor (TLR2 and TLR4) polymorphisms and chronic obstructive pulmonary disease. PLoS One 2012; 7: e43124. doi: 10.1371/journal.pone.0043124